For these reasons, we aimed to investigate the potential attendance of chimeric SS18-SSX fusion transcripts in the blood samples of SS patients after about six months of first combined therapy including surgical excision and chemotherapy and/or radiotherapy. Here, SS18 is linked to synovial sarcoma.